Acadia Pharmaceuticals Inc.
Key commercial leader for the U.S. launch of a new therapy for a rare neurodevelopmental disorder, shaping Acadia's rare disease franchise strategy. This role involves developing and executing innovative U.S. HCP marketing strategies, ensuring cross-functional integration and a best-in-class customer experience.
The position also supports global expansion and future pipeline opportunities.